世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の神経周囲療法市場レポート、歴史と予測2018-2029年、企業別、主要地域別、タイプ別、用途別内訳データ


Global Perineural Therapy Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

QYResearch社の硬膜周囲療法レポートは、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の硬膜周囲療法市場は、2022年の2億700万米ドルから2029年には3億4730... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年10月23日 US$3,350
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

QYResearch社の硬膜周囲療法レポートは、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の硬膜周囲療法市場は、2022年の2億700万米ドルから2029年には3億4730万米ドルに達すると予測され、2023年から2029年の期間中の年平均成長率は6.8%である。病院や診療所、外来手術センターからの需要が業界の主な促進要因である。

ウェルネス&ヘルスリサーチセンターによると、世界のウェルネス&ヘルス経済は4.8兆米ドルと評価された。2022年に大きな健康への支出が最も多い地域はアジア太平洋地域で、支出総額は1.68兆ドル、次いで北米(1.42兆ドル)、欧州(1.0兆ドル)となっている。国家衛生委員会健康発展研究センターが開示した健康産業会計分析データによると、2019年から2021年まで、健康サービス産業の市場規模は年平均7.0%成長し、具体的なデータは7.7兆元から8.8兆元に増加した。中国の健康産業の収入は2021年に8.0兆元に達し、8.1%増加した。

レポートの範囲
本レポートは、過去の分析(2018-2022年)と予測計算(2023-2029年)に基づき、読者が世界の神経周囲療法市場を多角的に包括的に理解することを目的とし、読者の戦略と意思決定に十分なサポートを提供します。

報告書に掲載されている企業、種類、用途、地域
企業別
メドトロニック
ボストン・サイエンティフィック社
アボット・ラボラトリーズ
アクソジェン
バクスターインターナショナル
リバノバ
インテグラライフサイエンス
ポリガニクス
ニューロペース
ソテリックス・メディカル
ネブロ
シナプスバイオメディカル
アレバ・ニューロセラピューティクス
コラーゲンマトリックス
ケリメディカル
バイオウェーブ・コーポレーション
ニューロシグマ
tVNSテクノロジーズGmbH
GiMerメディカル
タイプ別セグメント
内部神経刺激
外部神経刺激
用途別セグメント
病院および診療所
外来手術センター
その他
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国

アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア

ラテンアメリカ
メキシコ
ブラジル

中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦

本レポートの各章では、読者が神経周囲療法市場をさらに理解するための詳細情報を提供しています:
第1章:歴史と予測期間(2018-2023年、2024-2029年)における世界と地域の市場規模とCAGR。
第2章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品タイプと各タイプの収益分析。
第3章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途と各用途の収益分析。
第4章:企業競争状況、製品名企業の競争状況、収益、市場シェアとランキング、最新の開発計画、合併、買収情報などの詳細分析。
第5章:企業概要、企業の基本情報、硬膜周囲療法の紹介などをカバー。また、各社の売上高とグロスマージン、最近の開発状況もこの部分に含まれています。
第6章から第10章:北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカの国別レベル分析(収益別)。
第11章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク。
第12章:包括的調査に基づくQYResearch社の神経周囲療法市場の結論
第13章:QYResearchが採用した方法論とデータソース。


ページTOPに戻る


目次

1 Market Overview of Perineural Therapy
1.1 Perineural Therapy Market Overview
1.1.1 Perineural Therapy Product Scope
1.1.2 Perineural Therapy Market Status and Outlook
1.2 Global Perineural Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Perineural Therapy Market Size by Region (2018-2029)
1.4 Global Perineural Therapy Historic Market Size by Region (2018-2023)
1.5 Global Perineural Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Perineural Therapy Market Size (2018-2029)
1.6.1 North America Perineural Therapy Market Size (2018-2029)
1.6.2 Europe Perineural Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Perineural Therapy Market Size (2018-2029)
1.6.4 Latin America Perineural Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Perineural Therapy Market Size (2018-2029)
2 Perineural Therapy Market by Type
2.1 Introduction
2.1.1 Internal Neurostimulation
2.1.2 External Neurostimulation
2.2 Global Perineural Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Perineural Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Perineural Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Perineural Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Perineural Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Perineural Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Perineural Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Perineural Therapy Revenue Breakdown by Type (2018-2029)
3 Perineural Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Ambulatory Surgical Centers
3.1.3 Others
3.2 Global Perineural Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Perineural Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Perineural Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Perineural Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Perineural Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Perineural Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Perineural Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Perineural Therapy Revenue Breakdown by Application (2018-2029)
4 Perineural Therapy Competition Analysis by Players
4.1 Global Perineural Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Perineural Therapy as of 2022)
4.3 Date of Key Players Enter into Perineural Therapy Market
4.4 Global Top Players Perineural Therapy Headquarters and Area Served
4.5 Key Players Perineural Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Perineural Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Medtronic
5.1.1 Medtronic Profile
5.1.2 Medtronic Main Business
5.1.3 Medtronic Perineural Therapy Products, Services and Solutions
5.1.4 Medtronic Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Medtronic Recent Developments
5.2 Boston Scientific Corporation
5.2.1 Boston Scientific Corporation Profile
5.2.2 Boston Scientific Corporation Main Business
5.2.3 Boston Scientific Corporation Perineural Therapy Products, Services and Solutions
5.2.4 Boston Scientific Corporation Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Boston Scientific Corporation Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories Perineural Therapy Products, Services and Solutions
5.3.4 Abbott Laboratories Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 AxoGen Recent Developments
5.4 AxoGen
5.4.1 AxoGen Profile
5.4.2 AxoGen Main Business
5.4.3 AxoGen Perineural Therapy Products, Services and Solutions
5.4.4 AxoGen Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 AxoGen Recent Developments
5.5 Baxter International
5.5.1 Baxter International Profile
5.5.2 Baxter International Main Business
5.5.3 Baxter International Perineural Therapy Products, Services and Solutions
5.5.4 Baxter International Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Baxter International Recent Developments
5.6 LivaNova
5.6.1 LivaNova Profile
5.6.2 LivaNova Main Business
5.6.3 LivaNova Perineural Therapy Products, Services and Solutions
5.6.4 LivaNova Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 LivaNova Recent Developments
5.7 Integra LifeSciences
5.7.1 Integra LifeSciences Profile
5.7.2 Integra LifeSciences Main Business
5.7.3 Integra LifeSciences Perineural Therapy Products, Services and Solutions
5.7.4 Integra LifeSciences Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Integra LifeSciences Recent Developments
5.8 Polyganics
5.8.1 Polyganics Profile
5.8.2 Polyganics Main Business
5.8.3 Polyganics Perineural Therapy Products, Services and Solutions
5.8.4 Polyganics Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Polyganics Recent Developments
5.9 NeuroPace
5.9.1 NeuroPace Profile
5.9.2 NeuroPace Main Business
5.9.3 NeuroPace Perineural Therapy Products, Services and Solutions
5.9.4 NeuroPace Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 NeuroPace Recent Developments
5.10 Soterix Medical
5.10.1 Soterix Medical Profile
5.10.2 Soterix Medical Main Business
5.10.3 Soterix Medical Perineural Therapy Products, Services and Solutions
5.10.4 Soterix Medical Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Soterix Medical Recent Developments
5.11 Nevro
5.11.1 Nevro Profile
5.11.2 Nevro Main Business
5.11.3 Nevro Perineural Therapy Products, Services and Solutions
5.11.4 Nevro Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Nevro Recent Developments
5.12 Synapse Biomedical
5.12.1 Synapse Biomedical Profile
5.12.2 Synapse Biomedical Main Business
5.12.3 Synapse Biomedical Perineural Therapy Products, Services and Solutions
5.12.4 Synapse Biomedical Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Synapse Biomedical Recent Developments
5.13 Aleva Neurotherapeutics
5.13.1 Aleva Neurotherapeutics Profile
5.13.2 Aleva Neurotherapeutics Main Business
5.13.3 Aleva Neurotherapeutics Perineural Therapy Products, Services and Solutions
5.13.4 Aleva Neurotherapeutics Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Aleva Neurotherapeutics Recent Developments
5.14 Collagen Matrix
5.14.1 Collagen Matrix Profile
5.14.2 Collagen Matrix Main Business
5.14.3 Collagen Matrix Perineural Therapy Products, Services and Solutions
5.14.4 Collagen Matrix Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Collagen Matrix Recent Developments
5.15 KeriMedical
5.15.1 KeriMedical Profile
5.15.2 KeriMedical Main Business
5.15.3 KeriMedical Perineural Therapy Products, Services and Solutions
5.15.4 KeriMedical Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 KeriMedical Recent Developments
5.16 BioWave Corporation
5.16.1 BioWave Corporation Profile
5.16.2 BioWave Corporation Main Business
5.16.3 BioWave Corporation Perineural Therapy Products, Services and Solutions
5.16.4 BioWave Corporation Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.16.5 BioWave Corporation Recent Developments
5.17 NeuroSigma
5.17.1 NeuroSigma Profile
5.17.2 NeuroSigma Main Business
5.17.3 NeuroSigma Perineural Therapy Products, Services and Solutions
5.17.4 NeuroSigma Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.17.5 NeuroSigma Recent Developments
5.18 tVNS Technologies GmbH
5.18.1 tVNS Technologies GmbH Profile
5.18.2 tVNS Technologies GmbH Main Business
5.18.3 tVNS Technologies GmbH Perineural Therapy Products, Services and Solutions
5.18.4 tVNS Technologies GmbH Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.18.5 tVNS Technologies GmbH Recent Developments
5.19 GiMer Medical
5.19.1 GiMer Medical Profile
5.19.2 GiMer Medical Main Business
5.19.3 GiMer Medical Perineural Therapy Products, Services and Solutions
5.19.4 GiMer Medical Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.19.5 GiMer Medical Recent Developments
6 North America
6.1 North America Perineural Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Perineural Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Perineural Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Perineural Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Perineural Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Perineural Therapy Market Dynamics
11.1 Perineural Therapy Industry Trends
11.2 Perineural Therapy Market Drivers
11.3 Perineural Therapy Market Challenges
11.4 Perineural Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

 

ページTOPに戻る


 

Summary

Perineural Therapy report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Perineural Therapy market is projected to reach US$ 347.3 million in 2029, increasing from US$ 207 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Demand from Hospitals and Clinics and Ambulatory Surgical Centers are the major drivers for the industry.

According to our Wellness & Health Research Center, the global wellness & health economy was valued at US dollars 4.8 trillion. Asia Pacific was the region with the highest spending on big health in 2022, with a total spending of $1.68 trillion, followed by North America ($1.42 trillion) and Europe ($1.0 trillion). According to the health industry accounting analysis data disclosed by the Health Development Research Center of the National Health Commission, from 2019 to 2021, the market size of the health service industry grew by an average of 7.0% per year, and the specific data increased from 7.7 trillion yuan to 8.8 trillion yuan. China's health industry revenue reached 8.0 trillion yuan in 2021, with an increase of 8.1%.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Perineural Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
Medtronic
Boston Scientific Corporation
Abbott Laboratories
AxoGen
Baxter International
LivaNova
Integra LifeSciences
Polyganics
NeuroPace
Soterix Medical
Nevro
Synapse Biomedical
Aleva Neurotherapeutics
Collagen Matrix
KeriMedical
BioWave Corporation
NeuroSigma
tVNS Technologies GmbH
GiMer Medical
Segment by Type
Internal Neurostimulation
External Neurostimulation
Segment by Application
Hospitals and Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE

Each chapter of the report provides detailed information for readers to understand the Perineural Therapy market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Perineural Therapy introduction, etc. Perineural Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Perineural Therapy market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.



ページTOPに戻る


Table of Contents

1 Market Overview of Perineural Therapy
1.1 Perineural Therapy Market Overview
1.1.1 Perineural Therapy Product Scope
1.1.2 Perineural Therapy Market Status and Outlook
1.2 Global Perineural Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Perineural Therapy Market Size by Region (2018-2029)
1.4 Global Perineural Therapy Historic Market Size by Region (2018-2023)
1.5 Global Perineural Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Perineural Therapy Market Size (2018-2029)
1.6.1 North America Perineural Therapy Market Size (2018-2029)
1.6.2 Europe Perineural Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Perineural Therapy Market Size (2018-2029)
1.6.4 Latin America Perineural Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Perineural Therapy Market Size (2018-2029)
2 Perineural Therapy Market by Type
2.1 Introduction
2.1.1 Internal Neurostimulation
2.1.2 External Neurostimulation
2.2 Global Perineural Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Perineural Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Perineural Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Perineural Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Perineural Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Perineural Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Perineural Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Perineural Therapy Revenue Breakdown by Type (2018-2029)
3 Perineural Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Ambulatory Surgical Centers
3.1.3 Others
3.2 Global Perineural Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Perineural Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Perineural Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Perineural Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Perineural Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Perineural Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Perineural Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Perineural Therapy Revenue Breakdown by Application (2018-2029)
4 Perineural Therapy Competition Analysis by Players
4.1 Global Perineural Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Perineural Therapy as of 2022)
4.3 Date of Key Players Enter into Perineural Therapy Market
4.4 Global Top Players Perineural Therapy Headquarters and Area Served
4.5 Key Players Perineural Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Perineural Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Medtronic
5.1.1 Medtronic Profile
5.1.2 Medtronic Main Business
5.1.3 Medtronic Perineural Therapy Products, Services and Solutions
5.1.4 Medtronic Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Medtronic Recent Developments
5.2 Boston Scientific Corporation
5.2.1 Boston Scientific Corporation Profile
5.2.2 Boston Scientific Corporation Main Business
5.2.3 Boston Scientific Corporation Perineural Therapy Products, Services and Solutions
5.2.4 Boston Scientific Corporation Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Boston Scientific Corporation Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories Perineural Therapy Products, Services and Solutions
5.3.4 Abbott Laboratories Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 AxoGen Recent Developments
5.4 AxoGen
5.4.1 AxoGen Profile
5.4.2 AxoGen Main Business
5.4.3 AxoGen Perineural Therapy Products, Services and Solutions
5.4.4 AxoGen Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 AxoGen Recent Developments
5.5 Baxter International
5.5.1 Baxter International Profile
5.5.2 Baxter International Main Business
5.5.3 Baxter International Perineural Therapy Products, Services and Solutions
5.5.4 Baxter International Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Baxter International Recent Developments
5.6 LivaNova
5.6.1 LivaNova Profile
5.6.2 LivaNova Main Business
5.6.3 LivaNova Perineural Therapy Products, Services and Solutions
5.6.4 LivaNova Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 LivaNova Recent Developments
5.7 Integra LifeSciences
5.7.1 Integra LifeSciences Profile
5.7.2 Integra LifeSciences Main Business
5.7.3 Integra LifeSciences Perineural Therapy Products, Services and Solutions
5.7.4 Integra LifeSciences Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Integra LifeSciences Recent Developments
5.8 Polyganics
5.8.1 Polyganics Profile
5.8.2 Polyganics Main Business
5.8.3 Polyganics Perineural Therapy Products, Services and Solutions
5.8.4 Polyganics Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Polyganics Recent Developments
5.9 NeuroPace
5.9.1 NeuroPace Profile
5.9.2 NeuroPace Main Business
5.9.3 NeuroPace Perineural Therapy Products, Services and Solutions
5.9.4 NeuroPace Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 NeuroPace Recent Developments
5.10 Soterix Medical
5.10.1 Soterix Medical Profile
5.10.2 Soterix Medical Main Business
5.10.3 Soterix Medical Perineural Therapy Products, Services and Solutions
5.10.4 Soterix Medical Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Soterix Medical Recent Developments
5.11 Nevro
5.11.1 Nevro Profile
5.11.2 Nevro Main Business
5.11.3 Nevro Perineural Therapy Products, Services and Solutions
5.11.4 Nevro Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Nevro Recent Developments
5.12 Synapse Biomedical
5.12.1 Synapse Biomedical Profile
5.12.2 Synapse Biomedical Main Business
5.12.3 Synapse Biomedical Perineural Therapy Products, Services and Solutions
5.12.4 Synapse Biomedical Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Synapse Biomedical Recent Developments
5.13 Aleva Neurotherapeutics
5.13.1 Aleva Neurotherapeutics Profile
5.13.2 Aleva Neurotherapeutics Main Business
5.13.3 Aleva Neurotherapeutics Perineural Therapy Products, Services and Solutions
5.13.4 Aleva Neurotherapeutics Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Aleva Neurotherapeutics Recent Developments
5.14 Collagen Matrix
5.14.1 Collagen Matrix Profile
5.14.2 Collagen Matrix Main Business
5.14.3 Collagen Matrix Perineural Therapy Products, Services and Solutions
5.14.4 Collagen Matrix Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Collagen Matrix Recent Developments
5.15 KeriMedical
5.15.1 KeriMedical Profile
5.15.2 KeriMedical Main Business
5.15.3 KeriMedical Perineural Therapy Products, Services and Solutions
5.15.4 KeriMedical Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 KeriMedical Recent Developments
5.16 BioWave Corporation
5.16.1 BioWave Corporation Profile
5.16.2 BioWave Corporation Main Business
5.16.3 BioWave Corporation Perineural Therapy Products, Services and Solutions
5.16.4 BioWave Corporation Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.16.5 BioWave Corporation Recent Developments
5.17 NeuroSigma
5.17.1 NeuroSigma Profile
5.17.2 NeuroSigma Main Business
5.17.3 NeuroSigma Perineural Therapy Products, Services and Solutions
5.17.4 NeuroSigma Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.17.5 NeuroSigma Recent Developments
5.18 tVNS Technologies GmbH
5.18.1 tVNS Technologies GmbH Profile
5.18.2 tVNS Technologies GmbH Main Business
5.18.3 tVNS Technologies GmbH Perineural Therapy Products, Services and Solutions
5.18.4 tVNS Technologies GmbH Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.18.5 tVNS Technologies GmbH Recent Developments
5.19 GiMer Medical
5.19.1 GiMer Medical Profile
5.19.2 GiMer Medical Main Business
5.19.3 GiMer Medical Perineural Therapy Products, Services and Solutions
5.19.4 GiMer Medical Perineural Therapy Revenue (US$ Million) & (2018-2023)
5.19.5 GiMer Medical Recent Developments
6 North America
6.1 North America Perineural Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Perineural Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Perineural Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Perineural Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Perineural Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Perineural Therapy Market Dynamics
11.1 Perineural Therapy Industry Trends
11.2 Perineural Therapy Market Drivers
11.3 Perineural Therapy Market Challenges
11.4 Perineural Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る